Idorsia Ltd
SIX: IDIA.SW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Swiss Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jean-Paul Clozel
- Employees
- 636
- Headquarters
- Allschwil, Switzerland
- IPO year
- 2017
- Market cap
- CHF 835.5M
- Website
- https://www.idorsia.com
Loading IDIA…
Loading profile data…Frequently asked questions about IDIA
What does Idorsia Ltd (IDIA.SW) do?
Idorsia Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases. Idorsia Ltd has a collaboration agreement wit...
Where does IDIA.SW trade?
Idorsia Ltd (IDIA.SW) trades on the Swiss Exchange.
What sector is IDIA.SW in?
Idorsia Ltd (IDIA.SW) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Idorsia Ltd?
Jean-Paul Clozel is the chief executive officer of Idorsia Ltd (IDIA.SW).
Where is Idorsia Ltd headquartered?
Idorsia Ltd is headquartered in Switzerland.
Does IDIA.SW pay a dividend?
Idorsia Ltd (IDIA.SW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IDIA.SW go public?
Idorsia Ltd (IDIA.SW) completed its initial public offering in 2017.